Quick Takeaways
- Vifor (International) Ltd filed SCHEDULE 13D/A for Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) Common Stock, par value $0.001 per share (TVRD).
- Disclosed ownership: 2.2%.
- Date of event: 15 Apr 2025.
Vifor (International) Ltd - 15 Apr 2025 SCHEDULE 13D/A Report for Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) Common Stock, par value $0.001 per share (TVRD)
- Filing Manager
- Vifor (International) Ltd
- Reporting Manager
- Vifor (International) Ltd.
- Symbol
- TVRD
- Shares outstanding
- 9,339,318 shares
- Disclosed Ownership
- 205,465 shares
- Ownership
- 2.2%
- Form type
- SCHEDULE 13D/A
- Filing time
- 16 Apr 2025, 16:15:10 UTC
- Date of event
- 15 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Vifor (International) Ltd disclosed 2.2% ownership in Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) Common Stock, par value $0.001 per share (TVRD) on 15 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 16 Apr 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Vifor (International) Ltd. | 2.2% | 205,465 | 0 | 205,465 | /s/ Alexandros Sigalas | Alexandros Sigalas, Head of Finance, CSL Vifor | 0001675217 |
| CSL Limited | 2.2% | 205,465 | 0 | 205,465 | /s/ Fiona Mead | Fiona Mead, Company Secretary |